Cargando…

Managing inflammatory bowel disease in adolescent patients

Increasing numbers of adolescents are being diagnosed with Crohn’s disease or ulcerative colitis, the two main subtypes of inflammatory bowel disease. These young people face many short- and long-term challenges; one or more medical therapies may be required indefinitely; their disease may have grea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, J, Lemberg, DA, Day, AS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956483/
https://www.ncbi.nlm.nih.gov/pubmed/24729736
http://dx.doi.org/10.2147/AHMT.S37956
_version_ 1782307673591513088
author Bishop, J
Lemberg, DA
Day, AS
author_facet Bishop, J
Lemberg, DA
Day, AS
author_sort Bishop, J
collection PubMed
description Increasing numbers of adolescents are being diagnosed with Crohn’s disease or ulcerative colitis, the two main subtypes of inflammatory bowel disease. These young people face many short- and long-term challenges; one or more medical therapies may be required indefinitely; their disease may have great impact, in terms of their schooling and social activities. However, the management of adolescents with one of these incurable conditions needs to encompass more than just medical therapies. Growth, pubertal development, schooling, transition, adherence, and psychological well-being are all important aspects. A multidisciplinary team setting, catering to these components of care, is required to ensure optimal outcomes in adolescents with inflammatory bowel disease.
format Online
Article
Text
id pubmed-3956483
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39564832014-04-11 Managing inflammatory bowel disease in adolescent patients Bishop, J Lemberg, DA Day, AS Adolesc Health Med Ther Review Increasing numbers of adolescents are being diagnosed with Crohn’s disease or ulcerative colitis, the two main subtypes of inflammatory bowel disease. These young people face many short- and long-term challenges; one or more medical therapies may be required indefinitely; their disease may have great impact, in terms of their schooling and social activities. However, the management of adolescents with one of these incurable conditions needs to encompass more than just medical therapies. Growth, pubertal development, schooling, transition, adherence, and psychological well-being are all important aspects. A multidisciplinary team setting, catering to these components of care, is required to ensure optimal outcomes in adolescents with inflammatory bowel disease. Dove Medical Press 2014-01-06 /pmc/articles/PMC3956483/ /pubmed/24729736 http://dx.doi.org/10.2147/AHMT.S37956 Text en © 2014 Bishop et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Bishop, J
Lemberg, DA
Day, AS
Managing inflammatory bowel disease in adolescent patients
title Managing inflammatory bowel disease in adolescent patients
title_full Managing inflammatory bowel disease in adolescent patients
title_fullStr Managing inflammatory bowel disease in adolescent patients
title_full_unstemmed Managing inflammatory bowel disease in adolescent patients
title_short Managing inflammatory bowel disease in adolescent patients
title_sort managing inflammatory bowel disease in adolescent patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956483/
https://www.ncbi.nlm.nih.gov/pubmed/24729736
http://dx.doi.org/10.2147/AHMT.S37956
work_keys_str_mv AT bishopj managinginflammatoryboweldiseaseinadolescentpatients
AT lembergda managinginflammatoryboweldiseaseinadolescentpatients
AT dayas managinginflammatoryboweldiseaseinadolescentpatients